| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptor, Insulin | 40 | 2014 | 835 | 2.000 |
Why?
|
| Salicylates | 16 | 2017 | 127 | 1.750 |
Why?
|
| Insulin Resistance | 25 | 2017 | 3963 | 1.580 |
Why?
|
| Phosphoproteins | 34 | 2008 | 2448 | 1.480 |
Why?
|
| Inflammation | 27 | 2017 | 10773 | 1.260 |
Why?
|
| NF-kappa B | 18 | 2020 | 2490 | 1.100 |
Why?
|
| Phosphotyrosine | 42 | 2008 | 456 | 1.060 |
Why?
|
| Phosphopeptides | 34 | 1998 | 240 | 1.010 |
Why?
|
| src Homology Domains | 22 | 2003 | 361 | 0.980 |
Why?
|
| Insulin | 48 | 2014 | 6596 | 0.740 |
Why?
|
| Tyrosine | 41 | 2003 | 1440 | 0.710 |
Why?
|
| Protein Structure, Secondary | 16 | 2014 | 1229 | 0.670 |
Why?
|
| Protein Tyrosine Phosphatases | 14 | 2000 | 457 | 0.670 |
Why?
|
| Amino Acid Sequence | 89 | 2009 | 13446 | 0.670 |
Why?
|
| Obesity | 23 | 2016 | 12947 | 0.630 |
Why?
|
| Protein-Tyrosine Kinases | 28 | 2008 | 2425 | 0.620 |
Why?
|
| Diabetes Mellitus, Type 2 | 21 | 2017 | 12148 | 0.610 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 13 | 2016 | 2273 | 0.600 |
Why?
|
| Molecular Sequence Data | 88 | 2009 | 17635 | 0.600 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 13 | 2005 | 435 | 0.590 |
Why?
|
| Phosphotransferases | 12 | 1993 | 303 | 0.560 |
Why?
|
| Phenylalanine | 9 | 2004 | 366 | 0.530 |
Why?
|
| I-kappa B Kinase | 11 | 2013 | 250 | 0.520 |
Why?
|
| Adipose Tissue | 11 | 2016 | 3312 | 0.520 |
Why?
|
| Proto-Oncogene Proteins pp60(c-src) | 11 | 1995 | 145 | 0.500 |
Why?
|
| Adaptor Proteins, Signal Transducing | 17 | 2014 | 2898 | 0.500 |
Why?
|
| Muscular Atrophy | 5 | 2017 | 334 | 0.460 |
Why?
|
| Models, Molecular | 26 | 2011 | 5439 | 0.460 |
Why?
|
| Protein Structure, Tertiary | 11 | 2014 | 3792 | 0.450 |
Why?
|
| Profilins | 1 | 2013 | 65 | 0.440 |
Why?
|
| Adipose Tissue, White | 2 | 2013 | 365 | 0.440 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 6 | 2004 | 306 | 0.420 |
Why?
|
| GTPase-Activating Proteins | 2 | 2017 | 471 | 0.410 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 15 | 2008 | 2872 | 0.410 |
Why?
|
| Signal Transduction | 43 | 2022 | 23445 | 0.400 |
Why?
|
| Diabetes Complications | 2 | 2017 | 1315 | 0.380 |
Why?
|
| Haploinsufficiency | 1 | 2013 | 337 | 0.370 |
Why?
|
| Binding Sites | 41 | 2004 | 6055 | 0.370 |
Why?
|
| Glucose Transporter Type 4 | 2 | 2011 | 240 | 0.370 |
Why?
|
| Sequence Homology, Amino Acid | 20 | 2003 | 2748 | 0.360 |
Why?
|
| Lipodystrophy | 2 | 2009 | 145 | 0.360 |
Why?
|
| Insulin Receptor Substrate Proteins | 20 | 2008 | 557 | 0.360 |
Why?
|
| Blood Glucose | 15 | 2017 | 6391 | 0.350 |
Why?
|
| Subcutaneous Fat | 1 | 2013 | 393 | 0.340 |
Why?
|
| Phosphorylation | 41 | 2005 | 8320 | 0.330 |
Why?
|
| Glucose Intolerance | 1 | 2013 | 575 | 0.320 |
Why?
|
| Enzyme Activation | 20 | 2009 | 3597 | 0.320 |
Why?
|
| Animals | 107 | 2022 | 168459 | 0.320 |
Why?
|
| Crystallography, X-Ray | 13 | 2011 | 1990 | 0.310 |
Why?
|
| Macrophages | 7 | 2016 | 5769 | 0.290 |
Why?
|
| Structure-Activity Relationship | 18 | 2011 | 3076 | 0.290 |
Why?
|
| Carrier Proteins | 6 | 2005 | 4936 | 0.280 |
Why?
|
| DNA-Binding Proteins | 9 | 2007 | 9606 | 0.280 |
Why?
|
| Cricetinae | 17 | 2014 | 2423 | 0.280 |
Why?
|
| Protein Conformation | 25 | 2004 | 3968 | 0.280 |
Why?
|
| CHO Cells | 14 | 2014 | 1387 | 0.280 |
Why?
|
| Oncogene Protein pp60(v-src) | 8 | 1995 | 75 | 0.270 |
Why?
|
| Mice | 54 | 2022 | 81525 | 0.270 |
Why?
|
| Proto-Oncogene Proteins | 14 | 2005 | 4511 | 0.260 |
Why?
|
| Hepatocytes | 3 | 2011 | 1233 | 0.260 |
Why?
|
| Protein Binding | 28 | 2009 | 9351 | 0.260 |
Why?
|
| Muscle, Skeletal | 8 | 2020 | 4948 | 0.250 |
Why?
|
| Mice, Obese | 7 | 2012 | 420 | 0.250 |
Why?
|
| Chloroquine | 1 | 2006 | 274 | 0.250 |
Why?
|
| Proteins | 18 | 2002 | 6032 | 0.250 |
Why?
|
| Proinsulin | 7 | 1992 | 135 | 0.240 |
Why?
|
| Atherosclerosis | 3 | 2017 | 3408 | 0.230 |
Why?
|
| Sodium Salicylate | 2 | 2016 | 18 | 0.230 |
Why?
|
| Transcription Factors | 9 | 2009 | 12128 | 0.230 |
Why?
|
| Receptors, Antigen, T-Cell | 8 | 1998 | 2547 | 0.230 |
Why?
|
| Homeostasis | 5 | 2013 | 3323 | 0.220 |
Why?
|
| Glucose | 5 | 2017 | 4346 | 0.210 |
Why?
|
| Substrate Specificity | 15 | 1998 | 1791 | 0.210 |
Why?
|
| Cachexia | 1 | 2004 | 202 | 0.210 |
Why?
|
| Thrombosis | 1 | 2017 | 2942 | 0.210 |
Why?
|
| Kinetics | 24 | 1995 | 6374 | 0.210 |
Why?
|
| Hypoglycemic Agents | 4 | 2013 | 3085 | 0.210 |
Why?
|
| Dietary Fats | 4 | 2005 | 1995 | 0.200 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 8 | 1998 | 178 | 0.200 |
Why?
|
| Nuclear Proteins | 5 | 2007 | 5796 | 0.200 |
Why?
|
| Phosphatidylinositol 3-Kinases | 26 | 2002 | 2865 | 0.200 |
Why?
|
| Recombinant Proteins | 21 | 2002 | 6534 | 0.200 |
Why?
|
| Diaphragm | 2 | 2014 | 351 | 0.190 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 3 | 2009 | 126 | 0.190 |
Why?
|
| Apolipoprotein E3 | 2 | 2011 | 107 | 0.180 |
Why?
|
| Mice, Transgenic | 11 | 2020 | 9539 | 0.180 |
Why?
|
| Muscle Development | 2 | 2020 | 259 | 0.180 |
Why?
|
| Iron-Binding Proteins | 1 | 2000 | 79 | 0.180 |
Why?
|
| Lipoproteins, VLDL | 2 | 2011 | 201 | 0.180 |
Why?
|
| Peptide Fragments | 12 | 1995 | 5112 | 0.180 |
Why?
|
| Peptides | 16 | 1998 | 4358 | 0.170 |
Why?
|
| Transfection | 13 | 2003 | 5774 | 0.170 |
Why?
|
| Ligands | 4 | 2004 | 3272 | 0.170 |
Why?
|
| Interleukin-6 | 2 | 2007 | 3208 | 0.170 |
Why?
|
| Vasodilation | 2 | 2014 | 962 | 0.170 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 8 | 2000 | 120 | 0.160 |
Why?
|
| Humans | 121 | 2019 | 761504 | 0.160 |
Why?
|
| Mitochondria, Muscle | 1 | 2020 | 172 | 0.160 |
Why?
|
| Trypsin | 7 | 1995 | 495 | 0.160 |
Why?
|
| Mice, Inbred C57BL | 15 | 2020 | 22169 | 0.160 |
Why?
|
| Oligopeptides | 6 | 1995 | 1187 | 0.160 |
Why?
|
| Protein Kinases | 3 | 2005 | 1608 | 0.160 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 8 | 2000 | 223 | 0.150 |
Why?
|
| Dimerization | 3 | 2005 | 891 | 0.150 |
Why?
|
| Affinity Labels | 3 | 1993 | 107 | 0.150 |
Why?
|
| Rats | 21 | 2013 | 23742 | 0.150 |
Why?
|
| Aspirin | 3 | 2011 | 3133 | 0.150 |
Why?
|
| Glutathione Transferase | 9 | 1996 | 565 | 0.150 |
Why?
|
| Binding, Competitive | 9 | 1995 | 1141 | 0.140 |
Why?
|
| Circular Dichroism | 7 | 1994 | 344 | 0.140 |
Why?
|
| Glucose Tolerance Test | 6 | 2013 | 1178 | 0.140 |
Why?
|
| Recombinant Fusion Proteins | 22 | 2009 | 3734 | 0.140 |
Why?
|
| Cloning, Molecular | 9 | 2005 | 4174 | 0.140 |
Why?
|
| Cell Line | 19 | 2017 | 15601 | 0.140 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2013 | 1119 | 0.140 |
Why?
|
| Mutation | 16 | 2014 | 30052 | 0.140 |
Why?
|
| Maternal Behavior | 1 | 2019 | 307 | 0.140 |
Why?
|
| 3T3 Cells | 10 | 2000 | 1085 | 0.130 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2006 | 2803 | 0.130 |
Why?
|
| Retroviridae Proteins, Oncogenic | 4 | 1997 | 74 | 0.130 |
Why?
|
| Myostatin | 1 | 2017 | 129 | 0.130 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2016 | 542 | 0.130 |
Why?
|
| Object Attachment | 1 | 2019 | 326 | 0.130 |
Why?
|
| Phagocytosis | 1 | 2022 | 1528 | 0.130 |
Why?
|
| SH2 Domain-Containing Protein Tyrosine Phosphatases | 6 | 2000 | 43 | 0.130 |
Why?
|
| Genes, src | 6 | 1995 | 51 | 0.130 |
Why?
|
| Macromolecular Substances | 10 | 1996 | 1434 | 0.130 |
Why?
|
| Satellite Cells, Skeletal Muscle | 1 | 2016 | 126 | 0.130 |
Why?
|
| Type C Phospholipases | 5 | 1998 | 287 | 0.130 |
Why?
|
| Overweight | 2 | 2017 | 2417 | 0.130 |
Why?
|
| Mutagenesis, Site-Directed | 8 | 2000 | 1693 | 0.120 |
Why?
|
| Triglycerides | 3 | 2013 | 2461 | 0.120 |
Why?
|
| Two-Hybrid System Techniques | 3 | 2005 | 460 | 0.120 |
Why?
|
| Antigens, Viral, Tumor | 1 | 1995 | 153 | 0.120 |
Why?
|
| Hyperinsulinism | 4 | 2008 | 400 | 0.120 |
Why?
|
| Cell Cycle Proteins | 1 | 2006 | 3448 | 0.120 |
Why?
|
| Antigens, Polyomavirus Transforming | 2 | 1992 | 257 | 0.120 |
Why?
|
| Oxytocin | 1 | 2019 | 402 | 0.120 |
Why?
|
| Membrane Proteins | 4 | 2007 | 7856 | 0.120 |
Why?
|
| Enzyme Inhibitors | 5 | 2004 | 3712 | 0.120 |
Why?
|
| Fatty Acids | 1 | 2002 | 1808 | 0.120 |
Why?
|
| Endopeptidases | 3 | 1993 | 774 | 0.120 |
Why?
|
| Alternative Splicing | 2 | 2014 | 1093 | 0.120 |
Why?
|
| Osteocalcin | 1 | 2015 | 274 | 0.120 |
Why?
|
| Antigens, Differentiation | 2 | 2013 | 910 | 0.110 |
Why?
|
| Thiazolidinediones | 2 | 2013 | 461 | 0.110 |
Why?
|
| Liver | 7 | 2011 | 7529 | 0.110 |
Why?
|
| Cricetulus | 2 | 2014 | 814 | 0.110 |
Why?
|
| Mice, Knockout | 2 | 2019 | 14414 | 0.110 |
Why?
|
| Endotoxemia | 1 | 2014 | 196 | 0.110 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 1997 | 1626 | 0.100 |
Why?
|
| Insulinoma | 2 | 1992 | 121 | 0.100 |
Why?
|
| NIH 3T3 Cells | 1 | 2014 | 670 | 0.100 |
Why?
|
| Insulin Antibodies | 3 | 1993 | 28 | 0.100 |
Why?
|
| Somatostatin | 3 | 1983 | 447 | 0.100 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 1994 | 412 | 0.100 |
Why?
|
| Drug Design | 1 | 1997 | 1048 | 0.100 |
Why?
|
| Sarcopenia | 1 | 2017 | 372 | 0.100 |
Why?
|
| Peptides, Cyclic | 1 | 1994 | 392 | 0.100 |
Why?
|
| Cell Membrane | 6 | 1995 | 3688 | 0.100 |
Why?
|
| Protein Multimerization | 1 | 2017 | 983 | 0.100 |
Why?
|
| Apoptosis | 5 | 2022 | 9486 | 0.100 |
Why?
|
| Endothelium, Vascular | 2 | 2014 | 4431 | 0.100 |
Why?
|
| Chromatography, High Pressure Liquid | 11 | 1993 | 1541 | 0.100 |
Why?
|
| Diabetes Mellitus | 4 | 2009 | 5840 | 0.100 |
Why?
|
| Placebos | 3 | 2017 | 1667 | 0.100 |
Why?
|
| Hypertriglyceridemia | 2 | 2011 | 293 | 0.100 |
Why?
|
| Polyubiquitin | 1 | 2011 | 68 | 0.100 |
Why?
|
| Muscle Proteins | 2 | 2012 | 1154 | 0.090 |
Why?
|
| Prediabetic State | 1 | 2017 | 545 | 0.090 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2017 | 3245 | 0.090 |
Why?
|
| GRB2 Adaptor Protein | 8 | 1998 | 101 | 0.090 |
Why?
|
| Molecular Weight | 9 | 1995 | 2186 | 0.090 |
Why?
|
| Bone Remodeling | 1 | 2015 | 581 | 0.090 |
Why?
|
| Serine | 3 | 2004 | 830 | 0.090 |
Why?
|
| Magnetic Resonance Spectroscopy | 13 | 1996 | 3769 | 0.090 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2011 | 149 | 0.090 |
Why?
|
| Protein Structure, Quaternary | 2 | 2017 | 429 | 0.090 |
Why?
|
| Protein Processing, Post-Translational | 4 | 1995 | 1974 | 0.090 |
Why?
|
| Up-Regulation | 4 | 2012 | 4124 | 0.090 |
Why?
|
| Cytoplasmic Granules | 1 | 1992 | 574 | 0.090 |
Why?
|
| Gene Expression | 6 | 2016 | 7581 | 0.090 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2012 | 1809 | 0.090 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2011 | 262 | 0.080 |
Why?
|
| Endocytosis | 4 | 1997 | 957 | 0.080 |
Why?
|
| Protein Biosynthesis | 1 | 1997 | 2113 | 0.080 |
Why?
|
| Retroviridae Proteins | 1 | 1989 | 94 | 0.080 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2009 | 135 | 0.080 |
Why?
|
| PPAR gamma | 1 | 2012 | 484 | 0.080 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2011 | 250 | 0.080 |
Why?
|
| Tissue Transplantation | 1 | 2009 | 128 | 0.080 |
Why?
|
| Oxidative Stress | 2 | 2012 | 3113 | 0.080 |
Why?
|
| STAT3 Transcription Factor | 1 | 2013 | 871 | 0.080 |
Why?
|
| Vanadates | 4 | 2003 | 82 | 0.080 |
Why?
|
| Cathepsins | 1 | 2010 | 241 | 0.080 |
Why?
|
| Double-Blind Method | 6 | 2017 | 12341 | 0.080 |
Why?
|
| T-Lymphocytes | 10 | 1997 | 10194 | 0.080 |
Why?
|
| Adipokines | 1 | 2011 | 310 | 0.080 |
Why?
|
| Ubiquitin | 2 | 2004 | 839 | 0.080 |
Why?
|
| Blotting, Northern | 2 | 2003 | 1545 | 0.080 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2013 | 740 | 0.080 |
Why?
|
| Protein Precursors | 1 | 1992 | 1132 | 0.080 |
Why?
|
| Cell Hypoxia | 1 | 2011 | 656 | 0.080 |
Why?
|
| Calorimetry | 1 | 2008 | 129 | 0.080 |
Why?
|
| Male | 37 | 2020 | 360804 | 0.080 |
Why?
|
| DNA, Complementary | 3 | 2003 | 1991 | 0.080 |
Why?
|
| Isoenzymes | 4 | 1998 | 1687 | 0.080 |
Why?
|
| Salicylic Acid | 2 | 2013 | 62 | 0.080 |
Why?
|
| Prodrugs | 1 | 2010 | 261 | 0.080 |
Why?
|
| Clinical Trials as Topic | 3 | 2011 | 8002 | 0.070 |
Why?
|
| Base Sequence | 6 | 2002 | 12441 | 0.070 |
Why?
|
| Rats, Zucker | 2 | 2012 | 131 | 0.070 |
Why?
|
| Protein Engineering | 1 | 1991 | 549 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2012 | 4352 | 0.070 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2012 | 3080 | 0.070 |
Why?
|
| Sequence Alignment | 6 | 2009 | 2180 | 0.070 |
Why?
|
| Mutation, Missense | 3 | 2014 | 2571 | 0.070 |
Why?
|
| Interleukin-1 | 1 | 2011 | 1248 | 0.070 |
Why?
|
| Killer Cells, Natural | 1 | 2016 | 2200 | 0.070 |
Why?
|
| Photochemistry | 3 | 1993 | 239 | 0.070 |
Why?
|
| Chronic Disease | 2 | 2012 | 9318 | 0.070 |
Why?
|
| Hepatocyte Nuclear Factor 1 | 2 | 2003 | 27 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2013 | 10766 | 0.070 |
Why?
|
| Immunoglobulin Idiotypes | 1 | 1986 | 200 | 0.070 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2008 | 452 | 0.070 |
Why?
|
| Tissue Distribution | 2 | 2003 | 2265 | 0.070 |
Why?
|
| Insulin-Secreting Cells | 1 | 2013 | 901 | 0.070 |
Why?
|
| Insulin-Like Growth Factor I | 3 | 2012 | 1934 | 0.070 |
Why?
|
| Radioimmunoassay | 7 | 1986 | 862 | 0.070 |
Why?
|
| Membrane Glycoproteins | 3 | 1998 | 3702 | 0.070 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 2 | 2003 | 92 | 0.060 |
Why?
|
| Protein Isoforms | 2 | 2014 | 1699 | 0.060 |
Why?
|
| Muscle Contraction | 2 | 2014 | 1201 | 0.060 |
Why?
|
| Thinness | 1 | 2009 | 490 | 0.060 |
Why?
|
| Heat-Shock Proteins | 1 | 2009 | 795 | 0.060 |
Why?
|
| Peptide Mapping | 3 | 1996 | 262 | 0.060 |
Why?
|
| Aortic Diseases | 1 | 2011 | 735 | 0.060 |
Why?
|
| RNA, Messenger | 7 | 2012 | 12795 | 0.060 |
Why?
|
| Stress, Physiological | 1 | 2012 | 1403 | 0.060 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 2 | 2003 | 174 | 0.060 |
Why?
|
| Cytokines | 4 | 2014 | 7396 | 0.060 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2006 | 329 | 0.060 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 1986 | 357 | 0.060 |
Why?
|
| Shc Signaling Adaptor Proteins | 4 | 1997 | 46 | 0.060 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2016 | 1533 | 0.060 |
Why?
|
| Precipitin Tests | 2 | 2003 | 814 | 0.060 |
Why?
|
| Milk Proteins | 1 | 2005 | 163 | 0.060 |
Why?
|
| Aging | 3 | 2020 | 8708 | 0.060 |
Why?
|
| STAT5 Transcription Factor | 1 | 2005 | 265 | 0.060 |
Why?
|
| Leukocytes | 1 | 2012 | 2026 | 0.060 |
Why?
|
| Models, Structural | 2 | 1995 | 340 | 0.060 |
Why?
|
| Receptors, Antigen, B-Cell | 3 | 1996 | 545 | 0.060 |
Why?
|
| DNA Primers | 3 | 2002 | 2819 | 0.060 |
Why?
|
| Cardiovascular Diseases | 4 | 2017 | 15500 | 0.060 |
Why?
|
| Carbohydrate Metabolism | 1 | 2005 | 263 | 0.060 |
Why?
|
| X-Ray Diffraction | 2 | 2002 | 421 | 0.060 |
Why?
|
| Weight Loss | 2 | 2012 | 2684 | 0.050 |
Why?
|
| Janus Kinase 2 | 2 | 2005 | 560 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2004 | 286 | 0.050 |
Why?
|
| Diabetic Retinopathy | 1 | 2012 | 1274 | 0.050 |
Why?
|
| Protein Folding | 2 | 2000 | 870 | 0.050 |
Why?
|
| Adipocytes | 2 | 2010 | 1194 | 0.050 |
Why?
|
| Glycoproteins | 3 | 1998 | 2203 | 0.050 |
Why?
|
| Cell Transformation, Viral | 2 | 1995 | 526 | 0.050 |
Why?
|
| POU Domain Factors | 1 | 2002 | 47 | 0.050 |
Why?
|
| Cells, Cultured | 11 | 2016 | 18965 | 0.050 |
Why?
|
| Fatty Liver | 1 | 2009 | 790 | 0.050 |
Why?
|
| Escherichia coli | 6 | 1998 | 4217 | 0.050 |
Why?
|
| Annelida | 1 | 2002 | 7 | 0.050 |
Why?
|
| Hydrolysis | 2 | 1994 | 664 | 0.050 |
Why?
|
| Lamins | 1 | 2002 | 37 | 0.050 |
Why?
|
| Autoantibodies | 2 | 1993 | 2116 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 6 | 1998 | 6132 | 0.050 |
Why?
|
| Hindlimb | 1 | 2004 | 513 | 0.050 |
Why?
|
| Anura | 1 | 2002 | 80 | 0.050 |
Why?
|
| Trans-Activators | 2 | 2005 | 2856 | 0.050 |
Why?
|
| Diptera | 1 | 2002 | 50 | 0.050 |
Why?
|
| Female | 28 | 2019 | 392644 | 0.050 |
Why?
|
| GRB10 Adaptor Protein | 2 | 2002 | 23 | 0.050 |
Why?
|
| Blotting, Western | 3 | 2011 | 5035 | 0.050 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2014 | 1897 | 0.050 |
Why?
|
| Retina | 1 | 2012 | 2659 | 0.050 |
Why?
|
| Phenotype | 3 | 2012 | 16591 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2012 | 3492 | 0.050 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2011 | 1841 | 0.050 |
Why?
|
| Phosphatidylinositol 4,5-Diphosphate | 2 | 1999 | 124 | 0.050 |
Why?
|
| Liver Neoplasms, Experimental | 2 | 1992 | 189 | 0.050 |
Why?
|
| Lamin Type A | 1 | 2002 | 189 | 0.050 |
Why?
|
| Leucine | 2 | 2003 | 548 | 0.050 |
Why?
|
| Phosphates | 3 | 1995 | 770 | 0.050 |
Why?
|
| Codon | 1 | 2002 | 601 | 0.050 |
Why?
|
| Neoplasm Transplantation | 1 | 2004 | 2016 | 0.050 |
Why?
|
| DNA | 4 | 2002 | 7212 | 0.050 |
Why?
|
| C-Peptide | 5 | 2013 | 440 | 0.040 |
Why?
|
| Phosphatidylserines | 1 | 2022 | 188 | 0.040 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2001 | 318 | 0.040 |
Why?
|
| Citrate (si)-Synthase | 1 | 2020 | 48 | 0.040 |
Why?
|
| Islets of Langerhans | 1 | 1986 | 1341 | 0.040 |
Why?
|
| Crystallography | 2 | 1998 | 116 | 0.040 |
Why?
|
| Pneumonia | 1 | 2012 | 2143 | 0.040 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2002 | 361 | 0.040 |
Why?
|
| Friedreich Ataxia | 1 | 2000 | 77 | 0.040 |
Why?
|
| Phagocytes | 1 | 2022 | 295 | 0.040 |
Why?
|
| Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 6 | 1995 | 93 | 0.040 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2002 | 318 | 0.040 |
Why?
|
| Cross-Linking Reagents | 2 | 1993 | 687 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 3 | 2013 | 5789 | 0.040 |
Why?
|
| Single-Blind Method | 2 | 2013 | 1572 | 0.040 |
Why?
|
| Muscular Dystrophies | 1 | 2002 | 390 | 0.040 |
Why?
|
| Immune Tolerance | 1 | 2008 | 2303 | 0.040 |
Why?
|
| Hyperglycemia | 1 | 2008 | 1376 | 0.040 |
Why?
|
| Organ Size | 1 | 2004 | 2254 | 0.040 |
Why?
|
| Repressor Proteins | 2 | 2002 | 2986 | 0.040 |
Why?
|
| Molecular Structure | 4 | 1996 | 1880 | 0.040 |
Why?
|
| Clathrin | 2 | 1998 | 257 | 0.040 |
Why?
|
| Temperature | 2 | 2017 | 2226 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 1 | 4 | 1993 | 3415 | 0.040 |
Why?
|
| Bariatric Surgery | 1 | 2009 | 992 | 0.040 |
Why?
|
| Energy Metabolism | 1 | 2010 | 2882 | 0.040 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2000 | 368 | 0.040 |
Why?
|
| Lymphocyte Count | 2 | 2012 | 778 | 0.040 |
Why?
|
| Fishes | 1 | 2002 | 603 | 0.040 |
Why?
|
| Receptors, Oxytocin | 1 | 2019 | 69 | 0.040 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2011 | 3396 | 0.040 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 2 | 1997 | 489 | 0.040 |
Why?
|
| Histones | 1 | 2008 | 2580 | 0.040 |
Why?
|
| Gene Targeting | 1 | 2001 | 838 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 4 | 1994 | 1741 | 0.040 |
Why?
|
| Lysine | 2 | 2013 | 993 | 0.040 |
Why?
|
| Lipids | 3 | 2010 | 3341 | 0.040 |
Why?
|
| Plasmids | 1 | 2003 | 2269 | 0.040 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2002 | 857 | 0.040 |
Why?
|
| Adaptor Protein Complex mu Subunits | 1 | 1997 | 19 | 0.040 |
Why?
|
| Adaptor Protein Complex 3 | 1 | 1997 | 17 | 0.040 |
Why?
|
| Adaptor Protein Complex 1 | 1 | 1997 | 22 | 0.040 |
Why?
|
| GRB7 Adaptor Protein | 1 | 1997 | 2 | 0.040 |
Why?
|
| Adaptor Protein Complex 2 | 1 | 1997 | 42 | 0.040 |
Why?
|
| Adiponectin | 2 | 2013 | 1113 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2011 | 4580 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 2 | 1997 | 6075 | 0.030 |
Why?
|
| Arginine | 3 | 2013 | 934 | 0.030 |
Why?
|
| Disease Models, Animal | 3 | 2011 | 18252 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2001 | 1246 | 0.030 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2011 | 3204 | 0.030 |
Why?
|
| Muscles | 1 | 2001 | 1576 | 0.030 |
Why?
|
| Leptin | 3 | 2014 | 1597 | 0.030 |
Why?
|
| Transcription Factor AP-1 | 1 | 1998 | 321 | 0.030 |
Why?
|
| Protein Sorting Signals | 1 | 1997 | 279 | 0.030 |
Why?
|
| Thermodynamics | 3 | 2009 | 595 | 0.030 |
Why?
|
| Dynamins | 1 | 1997 | 139 | 0.030 |
Why?
|
| Myoblasts | 1 | 2017 | 231 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2003 | 1486 | 0.030 |
Why?
|
| Carnitine | 1 | 2017 | 252 | 0.030 |
Why?
|
| Ceramides | 1 | 2017 | 201 | 0.030 |
Why?
|
| Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1996 | 114 | 0.030 |
Why?
|
| Biotin | 2 | 1995 | 254 | 0.030 |
Why?
|
| Xenopus laevis | 1 | 2000 | 963 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2012 | 1320 | 0.030 |
Why?
|
| Pancreatic Neoplasms | 2 | 1992 | 5368 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 4 | 1996 | 110 | 0.030 |
Why?
|
| Phospholipase C gamma | 4 | 1998 | 131 | 0.030 |
Why?
|
| Immunosorbent Techniques | 2 | 1992 | 175 | 0.030 |
Why?
|
| Protein Stability | 1 | 2017 | 578 | 0.030 |
Why?
|
| Gene Expression Regulation | 4 | 2017 | 11903 | 0.030 |
Why?
|
| Receptors, Interleukin | 1 | 1996 | 243 | 0.030 |
Why?
|
| Pancreas | 2 | 1997 | 1691 | 0.030 |
Why?
|
| Somatostatin-28 | 3 | 1983 | 6 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-abl | 1 | 1995 | 140 | 0.030 |
Why?
|
| Receptors, Interleukin-2 | 1 | 1996 | 562 | 0.030 |
Why?
|
| Body Mass Index | 2 | 2010 | 12953 | 0.030 |
Why?
|
| Polyomavirus | 1 | 1995 | 234 | 0.030 |
Why?
|
| B-Lymphocytes | 3 | 1997 | 4758 | 0.030 |
Why?
|
| Transcription, Genetic | 2 | 2012 | 7594 | 0.030 |
Why?
|
| Second Messenger Systems | 1 | 1995 | 202 | 0.030 |
Why?
|
| Genetic Variation | 2 | 2002 | 6567 | 0.030 |
Why?
|
| Cell Compartmentation | 1 | 1995 | 384 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 4575 | 0.030 |
Why?
|
| Pyruvaldehyde | 1 | 2013 | 16 | 0.030 |
Why?
|
| Epidermal Growth Factor | 1 | 1997 | 701 | 0.030 |
Why?
|
| Micelles | 1 | 1994 | 192 | 0.030 |
Why?
|
| Gene Library | 1 | 1997 | 1059 | 0.030 |
Why?
|
| Rats, Wistar | 2 | 2012 | 1848 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2001 | 2665 | 0.030 |
Why?
|
| Body Weight | 1 | 2004 | 4618 | 0.030 |
Why?
|
| Disulfides | 1 | 1996 | 465 | 0.030 |
Why?
|
| Methionine | 2 | 1996 | 572 | 0.030 |
Why?
|
| Histidine | 2 | 1991 | 308 | 0.030 |
Why?
|
| Kidney | 2 | 2013 | 7048 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2020 | 1866 | 0.030 |
Why?
|
| Exercise | 2 | 2007 | 5890 | 0.030 |
Why?
|
| GTP Phosphohydrolases | 1 | 1997 | 517 | 0.030 |
Why?
|
| Streptozocin | 1 | 2013 | 194 | 0.030 |
Why?
|
| Avidin | 1 | 1993 | 43 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2004 | 2688 | 0.030 |
Why?
|
| Stem Cell Niche | 1 | 2016 | 345 | 0.030 |
Why?
|
| Chromatography, DEAE-Cellulose | 1 | 1992 | 81 | 0.030 |
Why?
|
| Lymphocyte Activation | 4 | 1996 | 5486 | 0.030 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 1993 | 201 | 0.030 |
Why?
|
| Malondialdehyde | 1 | 2012 | 112 | 0.030 |
Why?
|
| Deoxyguanosine | 1 | 2012 | 93 | 0.030 |
Why?
|
| Growth Substances | 1 | 1994 | 768 | 0.020 |
Why?
|
| Time Factors | 4 | 2013 | 39967 | 0.020 |
Why?
|
| Middle Aged | 12 | 2017 | 220895 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2014 | 731 | 0.020 |
Why?
|
| Iron | 1 | 2000 | 1793 | 0.020 |
Why?
|
| Brain | 1 | 2019 | 27112 | 0.020 |
Why?
|
| Aged | 10 | 2017 | 169289 | 0.020 |
Why?
|
| Brachial Artery | 1 | 2013 | 366 | 0.020 |
Why?
|
| Apolipoprotein C-I | 1 | 2011 | 13 | 0.020 |
Why?
|
| Mutagenesis | 2 | 1993 | 1232 | 0.020 |
Why?
|
| I-kappa B Proteins | 1 | 2012 | 211 | 0.020 |
Why?
|
| Enzymes, Immobilized | 1 | 1991 | 52 | 0.020 |
Why?
|
| Dogs | 3 | 1993 | 3839 | 0.020 |
Why?
|
| Antigens, CD | 3 | 1998 | 4003 | 0.020 |
Why?
|
| Rats, Inbred Strains | 1 | 1992 | 2088 | 0.020 |
Why?
|
| Adult | 14 | 2017 | 221177 | 0.020 |
Why?
|
| Microsomes | 1 | 1991 | 251 | 0.020 |
Why?
|
| Cytoskeletal Proteins | 2 | 1995 | 1342 | 0.020 |
Why?
|
| Oncogenes | 2 | 1996 | 1222 | 0.020 |
Why?
|
| Cholesterol, VLDL | 1 | 2011 | 70 | 0.020 |
Why?
|
| Thrombin | 1 | 1993 | 591 | 0.020 |
Why?
|
| Down-Regulation | 3 | 2011 | 2919 | 0.020 |
Why?
|
| Macrophage Activation | 1 | 2013 | 553 | 0.020 |
Why?
|
| Hybridomas | 3 | 1996 | 442 | 0.020 |
Why?
|
| Multigene Family | 1 | 2013 | 1076 | 0.020 |
Why?
|
| Epididymis | 1 | 2012 | 228 | 0.020 |
Why?
|
| Survival Rate | 1 | 2004 | 12725 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 1993 | 2496 | 0.020 |
Why?
|
| Amides | 1 | 1993 | 449 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 2013 | 1496 | 0.020 |
Why?
|
| Microinjections | 3 | 1996 | 321 | 0.020 |
Why?
|
| Quebec | 1 | 2010 | 141 | 0.020 |
Why?
|
| Anastomosis, Roux-en-Y | 1 | 2010 | 86 | 0.020 |
Why?
|
| Methyltyrosines | 1 | 1989 | 7 | 0.020 |
Why?
|
| Cell Count | 1 | 2013 | 1835 | 0.020 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 2 | 2002 | 178 | 0.020 |
Why?
|
| Proline | 1 | 1991 | 457 | 0.020 |
Why?
|
| Fibroblasts | 2 | 1997 | 4141 | 0.020 |
Why?
|
| ras Proteins | 1 | 1995 | 1054 | 0.020 |
Why?
|
| DNA Mutational Analysis | 3 | 1994 | 4111 | 0.020 |
Why?
|
| Glycine | 1 | 1992 | 663 | 0.020 |
Why?
|
| Interleukin-2 | 1 | 1996 | 1889 | 0.020 |
Why?
|
| Monosaccharide Transport Proteins | 2 | 2003 | 436 | 0.020 |
Why?
|
| Baculoviridae | 3 | 1994 | 115 | 0.020 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 1996 | 1784 | 0.020 |
Why?
|
| Aspartic Acid | 1 | 1991 | 576 | 0.020 |
Why?
|
| Risk Factors | 3 | 2017 | 74206 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 1995 | 1134 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2020 | 3612 | 0.020 |
Why?
|
| Oocytes | 1 | 1993 | 1166 | 0.020 |
Why?
|
| Cystatin C | 1 | 2010 | 269 | 0.020 |
Why?
|
| Diabetic Angiopathies | 1 | 2013 | 803 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2012 | 8181 | 0.020 |
Why?
|
| Treatment Outcome | 4 | 2017 | 64680 | 0.020 |
Why?
|
| Food | 2 | 1983 | 774 | 0.020 |
Why?
|
| Random Allocation | 1 | 2012 | 2395 | 0.020 |
Why?
|
| Regeneration | 1 | 2016 | 1511 | 0.020 |
Why?
|
| Oncogene Protein v-cbl | 2 | 1997 | 11 | 0.020 |
Why?
|
| Guanine Nucleotide Exchange Factors | 3 | 1996 | 569 | 0.020 |
Why?
|
| Caloric Restriction | 1 | 2010 | 299 | 0.020 |
Why?
|
| Tinnitus | 1 | 2010 | 196 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2007 | 15936 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2007 | 6403 | 0.020 |
Why?
|
| Immunoconjugates | 1 | 1995 | 954 | 0.020 |
Why?
|
| Tissue Extracts | 1 | 1986 | 141 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2011 | 1334 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2019 | 3548 | 0.020 |
Why?
|
| Albuminuria | 1 | 2010 | 657 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 2 | 1996 | 120 | 0.020 |
Why?
|
| Adenosine Triphosphate | 2 | 1989 | 1989 | 0.020 |
Why?
|
| Gene Expression Profiling | 2 | 2013 | 9420 | 0.020 |
Why?
|
| Cattle | 3 | 1998 | 3849 | 0.020 |
Why?
|
| ras Guanine Nucleotide Exchange Factors | 2 | 1995 | 34 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 3810 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2013 | 4021 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 3778 | 0.020 |
Why?
|
| Oncogene Protein v-crk | 2 | 1995 | 6 | 0.020 |
Why?
|
| Apolipoproteins E | 1 | 2011 | 1444 | 0.020 |
Why?
|
| Receptor, erbB-2 | 2 | 1993 | 2557 | 0.020 |
Why?
|
| Paxillin | 2 | 1995 | 86 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2012 | 1616 | 0.020 |
Why?
|
| Italy | 1 | 2007 | 842 | 0.010 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2009 | 789 | 0.010 |
Why?
|
| Avian Sarcoma Viruses | 2 | 1994 | 76 | 0.010 |
Why?
|
| Serum Albumin | 1 | 2007 | 672 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2012 | 2206 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 1997 | 4414 | 0.010 |
Why?
|
| Autophagy | 1 | 2012 | 1326 | 0.010 |
Why?
|
| Autoantigens | 1 | 2008 | 891 | 0.010 |
Why?
|
| Hydrogen Bonding | 2 | 1995 | 291 | 0.010 |
Why?
|
| Phosphatidylinositols | 2 | 1997 | 282 | 0.010 |
Why?
|
| Metabolic Clearance Rate | 1 | 1984 | 361 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2008 | 1967 | 0.010 |
Why?
|
| Cell Separation | 1 | 2009 | 1720 | 0.010 |
Why?
|
| Korea | 1 | 2003 | 98 | 0.010 |
Why?
|
| Glucose Transporter Type 2 | 1 | 2003 | 61 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2013 | 6310 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2009 | 3093 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2013 | 5869 | 0.010 |
Why?
|
| Models, Biological | 2 | 1997 | 9469 | 0.010 |
Why?
|
| Glucocorticoids | 1 | 2012 | 2161 | 0.010 |
Why?
|
| Dietary Carbohydrates | 1 | 2007 | 891 | 0.010 |
Why?
|
| Chick Embryo | 2 | 1995 | 982 | 0.010 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2005 | 615 | 0.010 |
Why?
|
| Inflammation Mediators | 1 | 2011 | 1886 | 0.010 |
Why?
|
| Physical Exertion | 1 | 2005 | 667 | 0.010 |
Why?
|
| Anisomycin | 1 | 2001 | 27 | 0.010 |
Why?
|
| Placenta | 1 | 1991 | 1709 | 0.010 |
Why?
|
| Homozygote | 1 | 2007 | 1776 | 0.010 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2005 | 687 | 0.010 |
Why?
|
| Linkage Disequilibrium | 1 | 2007 | 1998 | 0.010 |
Why?
|
| Conserved Sequence | 2 | 1995 | 1163 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2001 | 73 | 0.010 |
Why?
|
| Young Adult | 3 | 2014 | 59243 | 0.010 |
Why?
|
| Gastrointestinal Diseases | 1 | 2010 | 1200 | 0.010 |
Why?
|
| Adolescent | 4 | 2014 | 88319 | 0.010 |
Why?
|
| Chemical Phenomena | 2 | 1996 | 507 | 0.010 |
Why?
|
| Glucose Clamp Technique | 1 | 2001 | 263 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 2012 | 3826 | 0.010 |
Why?
|
| Exons | 1 | 2007 | 2391 | 0.010 |
Why?
|
| Postmenopause | 1 | 2010 | 2513 | 0.010 |
Why?
|
| Autoimmunity | 1 | 2008 | 1356 | 0.010 |
Why?
|
| Cell Division | 2 | 2000 | 4465 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2013 | 5972 | 0.010 |
Why?
|
| RNA | 1 | 2010 | 2726 | 0.010 |
Why?
|
| Ectoderm | 1 | 2000 | 137 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 2002 | 852 | 0.010 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2000 | 191 | 0.010 |
Why?
|
| Receptor, IGF Type 2 | 1 | 1998 | 35 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2003 | 1738 | 0.010 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2000 | 618 | 0.010 |
Why?
|
| Transcription Factor AP-2 | 1 | 1998 | 80 | 0.010 |
Why?
|
| ZAP-70 Protein-Tyrosine Kinase | 1 | 1997 | 69 | 0.010 |
Why?
|
| Naphthalenesulfonates | 1 | 1997 | 15 | 0.010 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 1998 | 201 | 0.010 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 1995 | 1745 | 0.010 |
Why?
|
| Freezing | 1 | 1998 | 311 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-crk | 1 | 1996 | 13 | 0.010 |
Why?
|
| Chromatin | 1 | 2008 | 2960 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 2002 | 2341 | 0.010 |
Why?
|
| Sequence Tagged Sites | 1 | 1996 | 96 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2001 | 2219 | 0.010 |
Why?
|
| Crk-Associated Substrate Protein | 1 | 1996 | 39 | 0.010 |
Why?
|
| Retinoblastoma-Like Protein p130 | 1 | 1996 | 73 | 0.010 |
Why?
|
| Chemistry, Physical | 1 | 1996 | 154 | 0.010 |
Why?
|
| Receptors, Interleukin-4 | 1 | 1996 | 64 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 1997 | 740 | 0.010 |
Why?
|
| Leucine Zippers | 1 | 1996 | 116 | 0.010 |
Why?
|
| Fluorine | 1 | 1996 | 83 | 0.010 |
Why?
|
| COS Cells | 1 | 1998 | 1130 | 0.010 |
Why?
|
| Malonates | 1 | 1995 | 43 | 0.010 |
Why?
|
| Enzyme Precursors | 1 | 1996 | 170 | 0.010 |
Why?
|
| Leukemia, B-Cell | 1 | 1996 | 84 | 0.010 |
Why?
|
| Alleles | 1 | 2007 | 6863 | 0.010 |
Why?
|
| Liver Cirrhosis | 1 | 1986 | 1935 | 0.010 |
Why?
|
| Son of Sevenless Proteins | 1 | 1995 | 27 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 1991 | 4320 | 0.010 |
Why?
|
| Pedigree | 1 | 2003 | 4542 | 0.010 |
Why?
|
| Ions | 1 | 1996 | 256 | 0.010 |
Why?
|
| Immediate-Early Proteins | 1 | 1998 | 449 | 0.010 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 1998 | 509 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2002 | 3606 | 0.010 |
Why?
|
| Age of Onset | 1 | 2002 | 3305 | 0.010 |
Why?
|
| Spodoptera | 1 | 1994 | 141 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2012 | 11528 | 0.010 |
Why?
|
| Reference Values | 1 | 2002 | 4920 | 0.010 |
Why?
|
| Spectrometry, Fluorescence | 1 | 1997 | 685 | 0.010 |
Why?
|
| Risk | 1 | 2007 | 9610 | 0.010 |
Why?
|
| Carboxypeptidases | 2 | 1985 | 154 | 0.010 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 1995 | 181 | 0.010 |
Why?
|
| Sequence Analysis | 1 | 1995 | 240 | 0.010 |
Why?
|
| Alanine | 1 | 1997 | 609 | 0.010 |
Why?
|
| Nitrogen Isotopes | 1 | 1994 | 84 | 0.010 |
Why?
|
| Oncogene Proteins v-abl | 1 | 1993 | 19 | 0.010 |
Why?
|
| Molecular Mimicry | 1 | 1995 | 213 | 0.010 |
Why?
|
| Leukemia, T-Cell | 1 | 1994 | 101 | 0.010 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 1995 | 198 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1998 | 1900 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2002 | 2455 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 1998 | 1529 | 0.010 |
Why?
|
| Fibroblast Growth Factors | 1 | 2000 | 867 | 0.010 |
Why?
|
| Boston | 1 | 2007 | 9326 | 0.010 |
Why?
|
| Injections, Subcutaneous | 2 | 1985 | 681 | 0.010 |
Why?
|
| Insulin Infusion Systems | 2 | 1985 | 217 | 0.010 |
Why?
|
| Moths | 1 | 1993 | 81 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 1995 | 867 | 0.010 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1993 | 297 | 0.010 |
Why?
|
| Chromatography, Gel | 2 | 1985 | 645 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2009 | 10445 | 0.010 |
Why?
|
| Biological Transport | 1 | 1998 | 2091 | 0.010 |
Why?
|
| Kidney Failure, Chronic | 1 | 1986 | 2471 | 0.010 |
Why?
|
| Chromatography, Thin Layer | 1 | 1993 | 213 | 0.010 |
Why?
|
| Inositol Phosphates | 1 | 1993 | 176 | 0.010 |
Why?
|
| Glycogen | 1 | 1993 | 251 | 0.010 |
Why?
|
| Sequence Homology | 1 | 1993 | 196 | 0.010 |
Why?
|
| Hypothalamus | 1 | 1998 | 999 | 0.010 |
Why?
|
| Antibodies | 2 | 1993 | 2418 | 0.010 |
Why?
|
| Catalysis | 1 | 1994 | 774 | 0.010 |
Why?
|
| Genotype | 1 | 2007 | 12990 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1994 | 779 | 0.010 |
Why?
|
| Computer Graphics | 1 | 1994 | 340 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 1996 | 727 | 0.010 |
Why?
|
| Models, Chemical | 1 | 1994 | 611 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 39106 | 0.010 |
Why?
|
| Coated Pits, Cell-Membrane | 1 | 1991 | 74 | 0.010 |
Why?
|
| Glutamates | 1 | 1993 | 389 | 0.010 |
Why?
|
| Xenopus | 1 | 1993 | 711 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2002 | 4243 | 0.010 |
Why?
|
| Oncogene Proteins, Viral | 1 | 1993 | 340 | 0.010 |
Why?
|
| GTP-Binding Proteins | 1 | 1995 | 951 | 0.010 |
Why?
|
| Point Mutation | 1 | 1996 | 1595 | 0.010 |
Why?
|
| Xenopus Proteins | 1 | 1993 | 434 | 0.010 |
Why?
|
| Molecular Conformation | 1 | 1991 | 544 | 0.010 |
Why?
|
| Polarography | 1 | 1989 | 10 | 0.010 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 1991 | 269 | 0.010 |
Why?
|
| Cytosol | 1 | 1993 | 888 | 0.010 |
Why?
|
| Pregnancy | 1 | 1991 | 29874 | 0.010 |
Why?
|
| Receptors, Immunologic | 1 | 1995 | 1410 | 0.010 |
Why?
|
| Child | 2 | 2014 | 80153 | 0.000 |
Why?
|
| Fluorescent Dyes | 1 | 1997 | 1903 | 0.000 |
Why?
|
| Genetic Testing | 1 | 2002 | 3537 | 0.000 |
Why?
|
| Annexins | 1 | 1988 | 38 | 0.000 |
Why?
|
| Phosphorus Radioisotopes | 1 | 1988 | 100 | 0.000 |
Why?
|
| Zinc | 1 | 1992 | 690 | 0.000 |
Why?
|
| Cell Cycle | 1 | 1996 | 2932 | 0.000 |
Why?
|
| Phospholipids | 1 | 1992 | 786 | 0.000 |
Why?
|
| Glutamic Acid | 1 | 1993 | 1176 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2010 | 41487 | 0.000 |
Why?
|
| Child, Preschool | 2 | 1993 | 42230 | 0.000 |
Why?
|
| Mammals | 1 | 1992 | 1132 | 0.000 |
Why?
|
| Carboxypeptidases A | 1 | 1985 | 37 | 0.000 |
Why?
|
| Tosylphenylalanyl Chloromethyl Ketone | 1 | 1985 | 8 | 0.000 |
Why?
|
| Electrophoresis, Disc | 1 | 1985 | 66 | 0.000 |
Why?
|
| Manganese | 1 | 1988 | 395 | 0.000 |
Why?
|
| Drosophila melanogaster | 1 | 1994 | 1712 | 0.000 |
Why?
|
| Sepharose | 1 | 1985 | 103 | 0.000 |
Why?
|
| Ultraviolet Rays | 1 | 1989 | 1080 | 0.000 |
Why?
|
| Acetic Anhydrides | 1 | 1984 | 2 | 0.000 |
Why?
|
| Carboxypeptidase B | 1 | 1984 | 6 | 0.000 |
Why?
|
| Immune Sera | 1 | 1985 | 606 | 0.000 |
Why?
|
| Chemistry | 1 | 1984 | 347 | 0.000 |
Why?
|
| Chromatography, Affinity | 1 | 1985 | 532 | 0.000 |
Why?
|
| Anti-Bacterial Agents | 1 | 2001 | 7407 | 0.000 |
Why?
|
| Immunoglobulin G | 1 | 1994 | 4544 | 0.000 |
Why?
|
| Genetic Vectors | 1 | 1992 | 3395 | 0.000 |
Why?
|
| Dexamethasone | 1 | 1988 | 1948 | 0.000 |
Why?
|
| Databases, Factual | 1 | 1995 | 7967 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 1 | 1996 | 9177 | 0.000 |
Why?
|
| Neurons | 1 | 1998 | 9463 | 0.000 |
Why?
|
| Fasting | 1 | 1983 | 1603 | 0.000 |
Why?
|
| Calcium | 1 | 1988 | 5722 | 0.000 |
Why?
|
| Swine | 1 | 1985 | 5915 | 0.000 |
Why?
|